- Home
- AHG vs AMRN Comparison
AHG vs AMRN Comparison
Compare AHG & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AHG
- AMRN
- Stock Information
- Founded
- AHG 2013
- AMRN 1989
- Country
- AHG China
- AMRN Ireland
- Employees
- AHG N/A
- AMRN N/A
- Industry
- AHG Business Services
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- AHG Consumer Discretionary
- AMRN Health Care
- Exchange
- AHG Nasdaq
- AMRN Nasdaq
- Market Cap
- AHG 240.9M
- AMRN 234.4M
- IPO Year
- AHG N/A
- AMRN 1993
- Fundamental
- Price
- AHG $1.06
- AMRN $0.59
- Analyst Decision
- AHG
- AMRN Hold
- Analyst Count
- AHG 0
- AMRN 3
- Target Price
- AHG N/A
- AMRN $1.00
- AVG Volume (30 Days)
- AHG 11.9K
- AMRN 739.0K
- Earning Date
- AHG 10-25-2024
- AMRN 10-30-2024
- Dividend Yield
- AHG N/A
- AMRN N/A
- EPS Growth
- AHG N/A
- AMRN N/A
- EPS
- AHG N/A
- AMRN N/A
- Revenue
- AHG $2,414,338.00
- AMRN $264,779,000.00
- Revenue This Year
- AHG N/A
- AMRN N/A
- Revenue Next Year
- AHG N/A
- AMRN N/A
- P/E Ratio
- AHG N/A
- AMRN N/A
- Revenue Growth
- AHG N/A
- AMRN N/A
- 52 Week Low
- AHG $0.53
- AMRN $0.56
- 52 Week High
- AHG $2.90
- AMRN $1.37
- Technical
- Relative Strength Index (RSI)
- AHG 48.20
- AMRN 46.99
- Support Level
- AHG $1.04
- AMRN $0.56
- Resistance Level
- AHG $1.30
- AMRN $0.61
- Average True Range (ATR)
- AHG 0.10
- AMRN 0.03
- MACD
- AHG -0.00
- AMRN 0.00
- Stochastic Oscillator
- AHG 20.00
- AMRN 33.33
About AHG Akso Health Group ADS
Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.